298. Hereditary pancreatitis
93 clinical trials,   168 drugs   (DrugBank: 51 drugs),   48 drug target genes,   134 drug target pathways
Searched query = "Hereditary pancreatitis", "Chronic pancreatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03283566 (ClinicalTrials.gov) | October 3, 2017 | 13/9/2017 | Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT | Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing Total Pancreatectomy and Autologous Islet Transplantation: A Clinical, Molecular, and Genomic Study | Chronic Pancreatitis;Insulin Dependent Diabetes | Drug: Hydroxychloroquine;Drug: Placebo | The Cleveland Clinic | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute);Stanford University | Completed | 18 Years | 65 Years | All | 9 | Phase 2 | United States |